O2Micro Announces Completion of Merger

O2Micro Announces Completion of Merger GEORGE TOWN, Grand Cayman, March 03, 2023 (GLOBE NEWSWIRE) -- O2Micro International Limited (NASDAQ Global Select Market: OIIM) (“O2Micro” or the “Company”), a global leader in the design, development and marketing of high-performance integrated circuits and solutions, today announced the completion of the merger (the “Merger”) with Rim Peak Technology Limited (“Merger Sub”), a wholly owned subsidiary of FNOF Precious Honour Limited (“Parent”), pursuant to the previously announced Agreement and Plan of Merger (the “Merger Agreement”), dated as of Sep...

O2Micro Announces Shareholders’ Approval of Merger Agreement

O2Micro Announces Shareholders’ Approval of Merger Agreement GEORGE TOWN, Grand Cayman, Feb. 01, 2023 (GLOBE NEWSWIRE) -- O2Micro International Limited (NASDAQ Global Select Market: OIIM) (“O2Micro” or the “Company”), a global leader in the design, development and marketing of high-performance integrated circuits and solutions, today announced that at an extraordinary general meeting of shareholders (the “EGM”) held on January 31, 2023 (Cayman Islands Time), the Company’s shareholders voted in favor of, among other things, the proposal to authorize and approve the previously announced agr...

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Both Recommend O2Micro Shareholders Vote “FOR” Proposed Going Private Transaction

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Both Recommend O2Micro Shareholders Vote “FOR” Proposed Going Private Transaction GEORGE TOWN, Grand Cayman, Jan. 19, 2023 (GLOBE NEWSWIRE) -- O2Micro International Limited (NASDAQ Global Select Market: OIIM) (“O2Micro” or the “Company”), a global leader in the design, development and marketing of high-performance integrated circuits and solutions, today announced that both Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis & Co., LLC (“Glass Lewis”) have recommended that O2Micro shareholders vote “FOR” the proposed...

PBSV: Steady as she goes

BCLI: KOL Event Gives Overview of the use of NurOwn® in Alzheimer’s Disease; Raising Valuation to $25/Share...

MNOV: FDA Gives OK to Initiate Clinical Trial of MN-166 to Prevent ARDS in COVID- 19 Patients...